Shopping News / Articles
Dia Medica Therapeutics Announces 75% Enrollment Milestone in Re MEDy2 Phase 2/3 Acute Ischemic Stroke Trial
5+ day, 12+ hour ago (164+ words) Re MEDy2 Phase 2/3 AIS Trial of DM199 Surpasses 75% of Enrollment Required to Trigger Pre-Specified Interim Analysis Interim Analysis by Independent DSMB Expected to Determine if a Sample Size Re-Estimation (Ranging Between 300 and 728 Patients) is Recommended Interim Analysis Anticipated to be Completed Before…...
Sionna Therapeutics Completes Enrollment in Preci SION CF Phase 2a Trial Evaluating NBD1 Stabilizer, SION-719, Added to Standard of Care in Participants with Cystic Fibrosis
4+ week, 13+ hour ago (409+ words) Topline data is on track for anticipated readout in the summer of 2026 WALTHAM, Mass. , April 27, 2026 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF), today…...
New Bedtime Pill May Treat Sleep Apnea Better
4+ hour, 23+ min ago (561+ words) ...
The FDA Is Encouraging AI Data in Clinical Trials - Black Doctor - Where Culture Meets Care
14+ hour, 50+ min ago (495+ words) When the FDA announced plans to expand real-time clinical trials and use AI in early-stage drug studies, it was pitched as a faster, more modern approach to medicine. For Black patients, who are underrepresented in research, the shift raises a…...
One-and-Done Heart Disease Prevention? Scientists Show It May Be Possible.
11+ hour, 50+ min ago (876+ words) If confirmed in larger studies, researchers hope the findings may lead to a one-and-done way to prevent heart disease in large numbers of people. Most gene therapies target rare diseases, but cardiovascular disease kills nearly 800, 000 Americans a year. "We have…...
FDA approves first gene therapy for inherited deafness, shown to restore hearing for children with rare condition | CNN
1+ mon, 2+ day ago (1359+ words) The US Food and Drug Administration on Thursday approved the first gene therapy for inherited hearing loss, a one-time treatment that proved to be life-changing for a small number of children in a clinical trial who were born without hearing....
A Single Dose of Psilocybin Could Ease Depression For Months, New Study Finds
1+ day, 1+ hour ago (580+ words) A single dose of psilocybin eased symptoms of depression within days, with benefits lasting for more than three months compared to placebo, our new study has found. The study, published in the journal JAMA Network Open, involved 35 people with recurring…...
Endeavor Health to build $175 M cancer, neuroscience center
4+ day, 6+ hour ago (19+ words) Endeavor Health build 175 M cancer neuroscience center at Northwest Community Hospital, offering advanced oncology and neuroscience care by 2029....
Penn study: Inconsistent GLP1 use may lead to weight gain - AOL
1+ week, 3+ day ago (357+ words) GLP-1 medications remain one of the most popular weight loss drugs on the market, but new research suggests consistency may be key to maintaining their effectiveness. A recent study from the University of Pennsylvania found that intermittent use of GLP…...
Advanced clinical therapy trial framework launched
1+ day, 15+ hour ago (519+ words) A new national framework aimed at supporting the expansion and standardisation of advanced therapy clinical trials across the UK has been launched by the Advanced Therapy Treatment Centre (ATTC) network, the Cell and Gene Therapy Catapult and Skills for Health....
Shopping
Please enter a search for detailed shopping results.